Core Viewpoint - Recently, Libo Biotech announced the completion of nearly 100 million yuan in Pre-A round financing, indicating increased capital recognition for its exploration in the RNA field and laying a solid foundation for future technological innovation and industrial development [2][3]. Company and Team Background - Libo Biotech was founded in September 2022 by Professor Zhou Yaoqi, Dr. Zhan Jian, and Dr. Fang Chao. Since its establishment, the company has received angel round financing from Sequoia China and Innovation Works [3]. - Notably, Libo Biotech is a project incubated by the Shenzhen Bay Laboratory, whose director is the globally renowned scientist Yan Ning. Yan Ning's support has attracted more industry attention and further enhanced the company's competitiveness in research and technology [3].
近亿元,颜宁旗下团队公司砺博生物完成Pre-A轮融资
仪器信息网·2025-08-20 03:55